Anti-CD34 monoclonal antibody
Anti-CD34 antibody for FACS & in-vivo assay
Go to CD34/CD34 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T66426-Ab-1/ GM-Tg-hg-T66426-Ab-2 | Anti-Human CD34 monoclonal antibody | Human |
| GM-Tg-hg-T66426-Ab-3/ GM-Tg-hg-T66426-Ab-4 | Anti-Human CD34 monoclonal antibody | Human |
| GM-Tg-rg-T66426-Ab-1/ GM-Tg-rg-T66426-Ab-2 | Anti-Rat CD34 monoclonal antibody | Rat |
| GM-Tg-mg-T66426-Ab-1/ GM-Tg-mg-T66426-Ab-2 | Anti-Mouse CD34 monoclonal antibody | Mouse |
| GM-Tg-cynog-T66426-Ab-1/ GM-Tg-cynog-T66426-Ab-2 | Anti-Cynomolgus/ Rhesus macaque CD34 monoclonal antibody | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T66426-Ab-1/ GM-Tg-felg-T66426-Ab-2 | Anti-Feline CD34 monoclonal antibody | Feline |
| GM-Tg-cang-T66426-Ab-1/ GM-Tg-cang-T66426-Ab-2 | Anti-Canine CD34 monoclonal antibody | Canine |
| GM-Tg-bovg-T66426-Ab-1/ GM-Tg-bovg-T66426-Ab-2 | Anti-Bovine CD34 monoclonal antibody | Bovine |
| GM-Tg-equg-T66426-Ab-1/ GM-Tg-equg-T66426-Ab-2 | Anti-Equine CD34 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. | GM-Tg-hg-T66426-Ab-1/ GM-Tg-hg-T66426-Ab-2; GM-Tg-rg-T66426-Ab-1/ GM-Tg-rg-T66426-Ab-2;GM-Tg-hg-T66426-Ab-3/ GM-Tg-hg-T66426-Ab-4; GM-Tg-rg-T66426-Ab-1/ GM-Tg-rg-T66426-Ab-2; GM-Tg-mg-T66426-Ab-1/ GM-Tg-mg-T66426-Ab-2; GM-Tg-cynog-T66426-Ab-1/ GM-Tg-cynog-T66426-Ab-2; GM-Tg-felg-T66426-Ab-1/ GM-Tg-felg-T66426-Ab-2; GM-Tg-cang-T66426-Ab-1/ GM-Tg-cang-T66426-Ab-2; GM-Tg-bovg-T66426-Ab-1/ GM-Tg-bovg-T66426-Ab-2; GM-Tg-equg-T66426-Ab-1/ GM-Tg-equg-T66426-Ab-2 |
| Products Name | Anti-CD34 monoclonal antibody |
| Format | mab |
| Target Name | CD34 |
| Protein Sub-location | Transmembrane Protein |
| Category of antibody | FACS/Biofunctional Antibody, Therapeutics Target antibody |
| Derivation (species) | Mouse/Human |
| CH1+2+3 Isotype (Receptor identification) |
IgG |
| Type of Light Chain (VD-LC) | N/A |
| Expression platform | Mammalian Expression |
| Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
| Tag | Fc |
| Products description | Pre-made anti-CD34 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
| Target Antigen | Products Developing | Multi-species CD34 VLP (virus-like particle) (Products Developing) |
| ORF Viral Vector | pGMLPm004921 | mouse Cd34 Lentivirus plasmid |
| ORF Viral Vector | vGMLPm004921 | mouse Cd34 Lentivirus particle |
Target information
| Target ID | GM-T66426 |
| Target Name | CD34 |
| Gene ID | 947,12490,305081,713858,415130,493884,281051,100051718 |
| Gene Symbol and Synonyms | CD34 |
| Uniprot Accession | P28906,Q28270 |
| Uniprot Entry Name | CD34_HUMAN,CD34_CANLF |
| Protein Sub-location | Transmembrane Protein |
| Category | Therapeutics Target |
| Disease | Cancer |
| Gene Ensembl | ENSG00000174059 |
| Target Classification | Tumor-associated antigen (TAA) |
The target: CD34, gene name: CD34, also named as . The protein encoded by this gene may play a role in the attachment of stem cells to the bone marrow extracellular matrix or to stromal cells. This single-pass membrane protein is highly glycosylated and phosphorylated by protein kinase C. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2011].
About Gmab


GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.

